MOTS-c and NAD+ Subcutaneous Guide

Mitochondrial Health, Longevity & Metabolic Optimization

Mitochondrial Health Anti-Aging Energy Enhancement Metabolic Support
N NAD+ N NAD+ MOTS-c Mitochondrial Synergy & Energy Production
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) and NAD+ (Nicotinamide Adenine Dinucleotide) represent a powerful combination for enhancing mitochondrial function, energy production, and longevity. When administered subcutaneously, these compounds work synergistically to combat age-related cellular decline and optimize metabolic health.

Understanding MOTS-c and NAD+

ATP Cellular Energy

MOTS-c is a 16-amino-acid peptide derived from the mitochondrial genome, known for its role in regulating metabolism, energy production, and cellular stress responses. This remarkable peptide acts as a signaling molecule that enhances mitochondrial function and promotes cellular health.

NAD+ is a vital coenzyme involved in redox reactions, DNA repair, and mitochondrial function. Unfortunately, NAD+ levels naturally decline with age by approximately 50% by age 50, making supplementation increasingly important for maintaining optimal cellular function.

When administered subcutaneously, both compounds can work together synergistically, as MOTS-c has been shown to naturally elevate NAD+ levels, creating an amplified effect for metabolic health, anti-aging, and energy optimization.

Individual Benefits

MOTS-c Benefits (5-10 mg weekly subcutaneous)
MOTS-c Metabolism MOTS-c Action
  • Improved Metabolic Function: Enhances glucose uptake in skeletal muscle, reduces insulin resistance, and promotes fat metabolism
  • Anti-Aging Protection: Boosts mitochondrial respiration, reduces inflammation and oxidative stress
  • Muscle and Bone Health: Improves muscle function, exercise performance, and bone metabolism
  • Immune Support: Enhances immune responses and helps cells adapt to metabolic stress
NAD+ Benefits (100-500 mg, 2-3 times weekly subcutaneous)
NAD+ DNA Repair NAD+ Function
  • Enhanced Energy Production: Boosts ATP production, combats fatigue, and supports cellular energy
  • Anti-Aging and DNA Repair: Activates sirtuins (SIRT1) for epigenetic regulation and longevity
  • Cognitive Support: Improves mental clarity, aids detoxification, and accelerates recovery
  • Metabolic Health: Supports weight management, insulin signaling, and cardiovascular function

Synergistic Benefits of the Combination

MOTS-c Metabolic Enhancer NAD+ Energy Coenzyme SYNERGY AMPLIFIED Enhanced Benefits Energy Longevity Metabolism Recovery Mitochondrial Optimization
1. Boosted Mitochondrial Function and Energy Production

MOTS-c elevates intracellular NAD+ levels (which naturally decline ~50% by age 50), amplifying NAD+'s role in ATP synthesis and mitochondrial biogenesis. Together, they may improve cellular energy, reduce fatigue, and enhance exercise tolerance through AMPK and SIRT1 pathway activation.

2. Enhanced Anti-Aging and Longevity

The combination targets age-related NAD+ depletion, with MOTS-c mitigating shortages via JAK and folate/methionine cycles. This may slow cellular senescence, support DNA repair, and reduce oxidative stress/inflammation, potentially extending healthspan.

3. Improved Metabolic Health and Insulin Regulation

Synergy in enhancing insulin sensitivity, glucose metabolism, and fat loss. MOTS-c boosts NAD+-dependent SIRT1 for better glycolytic effects, potentially aiding in obesity, diabetes, and metabolic syndrome management.

4. Reduced Inflammation and Cellular Protection

Combined action combats oxidative stress, supports immune clearance of damaged cells, and protects against age-related diseases. Enhanced DNA repair and stress adaptation capabilities.

Evidence and Mechanism Summary

Benefit Category Synergistic Mechanism Evidence Level
Energy & Mitochondria MOTS-c ↑ NAD+ → AMPK/SIRT1 activation Preclinical (mice), mechanistic studies
Anti-Aging NAD+ elevation delays senescence Observational (human longevity), animal models
Metabolism Improved insulin via shared pathways In vitro & in vivo (diabetes models)
Inflammation Reduced oxidative stress/DNA damage Cell studies, limited human data

Dosage and Administration

Typical Subcutaneous Dosing Protocols
  • MOTS-c: 5-10 mg weekly subcutaneous injection
  • NAD+: 100-500 mg, administered 2-3 times weekly subcutaneously
  • Combined Protocol: MOTS-c 5 mg + NAD+ 200 mg weekly (example dosing)
  • Administration: Subcutaneous delivery allows direct systemic absorption for targeted cellular effects

Important Considerations

Research Status and Safety
  • Evidence Gaps: Most data is from animal/in vitro studies; human trials on the combination are limited
  • Individual Variation: Benefits may vary by dose, age, and health status
  • Safety Profile: Generally well-tolerated in studies, but monitor for headaches, nausea, or hormonal changes
  • Contraindications: Not recommended for pregnant individuals or those with cancer history
  • Medical Supervision: Consult healthcare providers before starting any peptide therapy protocol

🔗 Subscribe to RSS Feed

This educational content is from 2025 research sources. MOTS-c and NAD+ are research compounds. Seek medical advice for personalized protocols and consider using tools like Peptide Health Tracker for monitoring.